P0562: Difference between revisions
Content added Content deleted
Michaeldakin (talk | contribs) (CSV import) |
Michaeldakin (talk | contribs) (Scary CSV import) |
||
Line 2: | Line 2: | ||
|policyid=PS086 |
|policyid=PS086 |
||
|policy=The NHS will be at the forefront of the development of genomics and cell therapies so that patients can benefit from new treatments for cancer and dementia |
|policy=The NHS will be at the forefront of the development of genomics and cell therapies so that patients can benefit from new treatments for cancer and dementia |
||
|category=140 NHS |
|||
| |
|subcategory=6 Medicine |
||
|charteritem=CR001 |
|charteritem=CR001 |
||
|keypolicyid=KP012 |
|keypolicyid=KP012 |
||
|stream=Public Services |
|stream=Public Services |
||
|approval=No |
|approval=No |
||
|updatedby=Michaeldakin |
|||
|dateupdated=04/09/2021 |
|||
}} |
}} |
Revision as of 00:02, 5 September 2021
Policy
Policy ID: | PS086 | Policy: | The NHS will be at the forefront of the development of genomics and cell therapies so that patients can benefit from new treatments for cancer and dementia |
Category: | NHS | SubCategory: | Medicine |
Description and Support Documents
Corresponding Charter Article
C1. Health
Everyone has a right to excellent medical care. A public NHS provides the most effective way of providing universal care. We guarantee a publicly owned health service and the end to privatisation.
Amendments
No results